VABYSMO
European shares tick higher as earnings kick into high gearApart from the ongoing corporate earnings season, which investors are using as a gauge for the continent's economy, all eyes are on the sti...
Roche considering divesting $1.9 billion cancer data startup: reportRoche had paid $1.9 billion for New-York based Flatiron Health in 2018 to speed its development of cancer medicines and support its efforts...
Roche launches top selling eye drug Vabysmo in IndiaRoche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The...
- Load More